REGENERATE – AMI

Phase 1

Conditions: Patients with acute ST-elevation myocardial infarction will be treated with progenitor cells after acute revascularisation.
MedDRA version: 14.1Level: LLTClassification code 10028597Term: Myocardial infarction acuteSystem Organ Class: 10007541 - Cardiac disorders

Registration Number: EUCTR2010-021277-36-DK

Lead Sponsor: Queen Mary, University of London

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: ot Recruiting

Sex: All

Target Recruitment: 100

Inclusion Criteria

Acute ST-elevation infarction in the left anterior descendens artery treated acutely with percutaneous balloon angioplasty or stent implantation.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Active infection
Neoplasma
Cerebrovascular infarction
Reduced kidney function

Study & Design

Study Type: Interventional clinical trial of medicinal product

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Main Objective: To improve post-infarction myocardial function;Secondary Objective: To improve myocardial perfusion and infarct size.;Primary end point(s): Left ventricular ejection fraction at 12 months follow-up

Secondary Outcome Measures